Involvement of Wnt/β-catenin signaling in the mesenchymal stem cells promote metastatic growth and chemoresistance of cholangiocarcinoma

Oncotarget

Volumn 6, Issue 39, 2015, Pages 42276-42289

  Wang, Weiwei ^a   Zhong, Wei ^a   Yuan, Jiahui ^a   Yan, Congcong ^a   Hu, Shaoping ^a   Tong, Yinping ^a   Mao, Yubin ^a   Hu, Tianhui ^a   Zhang, Bing ^a   Song, Gang ^a  

^a XIAMEN UNIVERSITY   (China)

Author keywords

Chemoresistance; Cholangiocarcinoma; Metastasis; MSCs; catenin

Indexed keywords

BETA CATENIN; CYCLIN D1; MYC PROTEIN; WNT PROTEIN; CONDITIONED MEDIUM; GINSENOSIDE; GINSENOSIDE M1;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE DUCT CARCINOMA; CANCER RESISTANCE; CARCINOGENESIS; CELL MIGRATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MALE; MESENCHYMAL STEM CELL; METASTASIS POTENTIAL; MIDDLE AGED; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; APOPTOSIS; BAGG ALBINO MOUSE; BILE DUCT NEOPLASMS; CELL CULTURE; CHOLANGIOCARCINOMA; CONDITIONED MEDIUM; CONFOCAL MICROSCOPY; CYTOLOGY; DRUG EFFECTS; DRUG RESISTANCE; DRUG SCREENING; GENE EXPRESSION REGULATION; GENETICS; MESENCHYMAL STROMA CELL; METABOLISM; METASTASIS; NUDE MOUSE; PHARMACOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE; TUMOR VOLUME; WESTERN BLOTTING; WNT SIGNALING PATHWAY;

ANIMALS; APOPTOSIS; BILE DUCT NEOPLASMS; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL PROLIFERATION; CELLS, CULTURED; CHOLANGIOCARCINOMA; CULTURE MEDIA, CONDITIONED; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; GINSENOSIDES; HUMANS; MALE; MESENCHYMAL STROMAL CELLS; MICE, INBRED BALB C; MICE, NUDE; MICROSCOPY, CONFOCAL; NEOPLASM METASTASIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR BURDEN; WNT SIGNALING PATHWAY; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84951761502     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.5514     Document Type: Article

References (40)

1. Razumilava N, Gores GJ. Cholangiocarcinoma. Lancet. 2014; 383:2168-2179.
2. de Groen PC, Gores GJ, LaRusso NF, Gunderson LL, Nagorney DM. Biliary tract cancers. The New England journal of medicine. 1999; 341:1368-1378.
3. Blechacz B, Gores GJ. Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment. Hepatology. 2008; 48:308-321.
4. Dickson PV, Behrman SW. Distal cholangiocarcinoma. The Surgical clinics of North America. 2014; 94:325-342.
5. Zhang W, Yan LN. Perihilar cholangiocarcinoma: Current therapy. World journal of gastrointestinal pathophysiology. 2014; 5:344-354.
6. Pittenger MF. Multilineage Potential of Adult Human Mesenchymal Stem Cells. Science. 1999; 284:143-147.
7. Karp JM, Leng Teo GS. Mesenchymal stem cell homing: the devil is in the details. Cell stem cell. 2009; 4:206-216.
8. G Chamberlain JF, B Ashton, J Middleton. Concise Review: Mesenchymal Stem Cells: Their Phenotype, Differentiation Capacity, Immunological Features, and Potential for Homing. Stem cells. 2007; 25:2739-2749.
9. Spaeth E, Klopp A, Dembinski J, AndreeffM, Marini F. Inflammation and tumor microenvironments: defining the migratory itinerary of mesenchymal stem cells. Gene therapy. 2008; 15:730-738.
10. Karnoub AE, Dash AB, Vo AP, Sullivan A, Brooks MW, Bell GW, Richardson AL, Polyak K, Tubo R, Weinberg RA. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature. 2007; 449:557-563.
11. Rattigan Y, Hsu JM, Mishra PJ, Glod J, Banerjee D. Interleukin 6 mediated recruitment of mesenchymal stem cells to the hypoxic tumor milieu. Experimental cell research. 2010; 316:3417-3424.
12. Jung Y, Kim JK, Shiozawa Y, Wang J, Mishra A, Joseph J, Berry JE, McGee S, Lee E, Sun H, Wang J, Jin T, Zhang H, Dai J, Krebsbach PH, Keller ET, et al. Recruitment of mesenchymal stem cells into prostate tumours promotes metastasis. Nature communications. 2013; 4:1795.
13. Gutova M, Najbauer J, Frank RT, Kendall SE, Gevorgyan A, Metz MZ, Guevorkian M, Edmiston M, Zhao D, Glackin CA, Kim SU, Aboody KS. Urokinase plasminogen activator and urokinase plasminogen activator receptor mediate human stem cell tropism to malignant solid tumors. Stem cells. 2008; 26:1406-1413.
14. Spaeth EL, Dembinski JL, Sasser AK, Watson K, Klopp A, Hall B, AndreeffM, Marini F. Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progression. PloS one. 2009; 4:e4992.
15. Uchibori R, Tsukahara T, Ohmine K, Ozawa K. Cancer gene therapy using mesenchymal stem cells. International journal of hematology. 2014; 99:377-382.
16. Guan J, Chen J. Mesenchymal stem cells in the tumor microenvironment. Biomedical reports. 2013; 1:517-521.
17. Chen DR, Lu DY, Lin HY, Yeh WL. Mesenchymal stem cell-induced doxorubicin resistance in triple negative breast cancer. BioMed research international. 2014; 2014:532161.
18. Kucerova L, Skolekova S, Matuskova M, Bohac M, Kozovska Z. Altered features and increased chemosensitivity of human breast cancer cells mediated by adipose tissue-derived mesenchymal stromal cells. BMC cancer. 2013; 13:535.
19. Xia B, Tian C, Guo S, Zhang L, Zhao D, Qu F, Zhao W, Wang Y, Wu X, Da W, Wei S, Zhang Y. c-Myc plays part in drug resistance mediated by bone marrow stromal cells in acute myeloid leukemia. Leukemia research. 2015; 39:92-99.
20. Nag SA, Qin JJ, Wang W, Wang MH, Wang H, Zhang R. Ginsenosides as Anticancer Agents: In vitro and in vivo Activities, Structure-Activity Relationships, and Molecular Mechanisms of Action. Frontiers in pharmacology. 2012; 3:25.
21. Yang XD, Yang YY, Ouyang DS, Yang GP. A review of biotransformation and pharmacology of ginsenoside compound K. Fitoterapia. 2015; 100:208-220.
22. Ming Y, Chen Z, Chen L, Lin D, Tong Q, Zheng Z, Song G. Ginsenoside compound K attenuates metastatic growth of hepatocellular carcinoma, which is associated with the translocation of nuclear factor-kappaB p65 and reduction of matrix metalloproteinase-2/9. Planta medica. 2011; 77:428-433.
23. Uchibori R, Tsukahara T, Mizuguchi H, Saga Y, Urabe M, Mizukami H, Kume A, Ozawa K. NF-kappaB activity regulates mesenchymal stem cell accumulation at tumor sites. Cancer research. 2013; 73:364-372.
24. Doucette T, Rao G, Yang Y, Gumin J, Shinojima N, Bekele BN, Qiao W, Zhang W, Lang FF. Mesenchymal stem cells display tumor-specific tropism in an RCAS/Ntv-a glioma model. Neoplasia. 2011; 13:716-725.
25. Li GC, Ye QH, Xue YH, Sun HJ, Zhou HJ, Ren N, Jia HL, Shi J, Wu JC, Dai C, Dong QZ, Qin LX. Human mesenchymal stem cells inhibit metastasis of a hepatocellular carcinoma model using the MHCC97-H cell line. Cancer science. 2010; 101:2546-2553.
26. Klopp AH, Lacerda L, Gupta A, Debeb BG, Solley T, Li L, Spaeth E, Xu W, Zhang X, Lewis MT, Reuben JM, Krishnamurthy S, Ferrari M, Gaspar R, Buchholz TA, Cristofanilli M, et al. Mesenchymal stem cells promote mammosphere formation and decrease E-cadherin in normal and malignant breast cells. PloS one. 2010; 5:e12180.
27. Song B, Kim B, Choi SH, Song KY, Chung YG, Lee YS, Park G. Mesenchymal stromal cells promote tumor progression in fibrosarcoma and gastric cancer cells. Korean journal of pathology. 2014; 48:217-224.
28. Zhang C, Zhai W, Xie Y, Chen Q, Zhu W, Sun X. Mesenchymal stem cells derived from breast cancer tissue promote the proliferation and migration of the MCF-7 cell line. Oncology letters. 2013; 6:1577-1582.
29. Takahara K, Ii M, Inamoto T, Komura K, Ibuki N, Minami K, Uehara H, Hirano H, Nomi H, Kiyama S, Asahi M, Azuma H. Adipose-derived stromal cells inhibit prostate cancer cell proliferation inducing apoptosis. Biochemical and biophysical research communications. 2014; 446:1102-1107.
30. Han I, Yun M, Kim EO, Kim B, Jung MH, Kim SH. Umbilical cord tissue-derived mesenchymal stem cells induce apoptosis in PC-3 prostate cancer cells through activation of JNK and downregulation of PI3K/AKT signaling. Stem cell research & therapy. 2014; 5:54.
31. Juan Liu GH, Hui Liu, Chengyong Qin. Suppression of Cholangiocarcinoma Cell Growth by Human Umbilical Cord Mesenchymal Stem Cells: A Possible Role of Wnt and Akt Signaling. PloS one. 2013; 8:e62844.
32. Tse JC, Kalluri R. Mechanisms of metastasis: epithelialto-mesenchymal transition and contribution of tumor microenvironment. Journal of cellular biochemistry. 2007; 101:816-829.
33. Techasen A, Loilome W, Namwat N, Khuntikeo N, Puapairoj A, Jearanaikoon P, Saya H, Yongvanit P. Loss of E-cadherin promotes migration and invasion of cholangiocarcinoma cells and serves as a potential marker of metastasis. Tumour biology: the journal of the International Society for Oncodevelopmental Biology and Medicine. 2014; 35:8645-8652.
34. Ochoa-Hernandez AB, Juarez-Vazquez CI, Rosales-Reynoso MA, Barros-Nunez P. Wnt-beta-catenin signaling pathway and its relationship with cancer [Article in Spanish]. Cirugia y cirujanos. 2012; 80:389-398.
35. Kim W, Kim M, Jho EH. Wnt/beta-catenin signalling: from plasma membrane to nucleus. The Biochemical journal. 2013; 450:9-21.
36. Sugimachi K, Taguchi K, Aishima S, Tanaka S, Shimada M, Kajiyama K, Sugimachi K, Tsuneyoshi M. Altered expression of beta-catenin without genetic mutation in intrahepatic cholangiocarcinoma. Modern pathology. 2001; 14:900-905.
37. Valle J, Wasan H, Palmer DH, Cunningham D, Anthoney A, Maraveyas A, Madhusudan S, Iveson T, Hughes S, Pereira SP, Roughton M, Bridgewater J Investigators ABCT. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. The New England journal of medicine. 2010; 362:1273-1281.
38. Khan SA, Davidson BR, Goldin RD, Heaton N, Karani J, Pereira SP, Rosenberg WM, Tait P, Taylor-Robinson SD, Thillainayagam AV, Thomas HC, Wasan H British Society of G. Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update. Gut. 2012; 61:1657-1669.
39. Lu LL, Liu YJ, Yang SG, Zhao QJ, Wang X, Gong W, Han ZB, Xu ZS, Lu YX, Liu D, Chen ZZ, Han ZC. Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials. Haematologica. 2006; 91:1017-1026.
40. Lin D, Zhong W, Li J, Zhang B, Song G, Hu T. Involvement of BID translocation in glycyrrhetinic acid and 11-deoxy glycyrrhetinic acid-induced attenuation of gastric cancer growth. Nutrition and cancer. 2014; 66:463-473.